Interferon alfa-2a tretinoin in patients with metastatic renal cell carcinoma: a pilot study.
Paule
B
B
Service of Blood Disorders and Tumors, Hôpital Paul Brousse, Villejuif, France.
Bonhomme-Faivre
L
L
Rudant
E
E
Ferrière
F
F
D000368:Aged; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011994:Recombinant Proteins; D015996:Survival Rate; D014212:Tretinoin / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014212:Tretinoin